Anti-CD4 scFv-Fc antibodies are engineered proteins that combine single-chain variable fragments (scFvs) targeting the CD4 antigen with an Fc region, enhancing their stability and efficacy. They are primarily used in immunological research, therapy for autoimmune diseases, and as potential tools in cancer immunotherapy. These antibodies can modulate T cell responses, making them useful in various applications including flow cytometry, immunoprecipitation, and targeted drug delivery. Their versatility and specificity position them as valuable assets in both basic and translational research.
The TRX1 antibody should be administered at a level that saturates all CD4 receptors in the primate being treated, implying a high affinity to ensure effective binding and occupancy of the CD4 receptors.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-039 | Anti-Human CD4 Recombinant Antibody (Zanolimumab) | Neut, ELISA, IF, IP, FuncS, FC, IHC | IgG1 - kappa |
There are currently no Customer reviews or questions for VS-0325-FY64. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.